source
- Vera Therapeutics receives accelerated approval for Trutakna to treat IgA nephropathyVera Therapeutics announced that its fusion protein atacicept, branded as Trutakna, has been granted accelerated approval by the FDA for the treatment of immunoglobulin A nephropathy, a chronic aut…
- FDA greenlights Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has approved a new therapy from Vera Therapeutics aimed at treating IgA nephropathy, a chronic autoimmune kidney disorder. The drug, called Trutakna, is intended for patients with this con…